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Abstract
Objectives: Clinically stable children with HIV can have neuromotor, attention, memory, visual–spatial, and
executive function impairments. We evaluated neuropsychological and behavioral benefits of computerized
cognitive rehabilitation training (CCRT) in Ugandan HIV children.
Design: One hundred fifty-nine rural Ugandan children with WHO Stage I or II HIV disease (6 to 12 years; 77
boys, 82 girls; M = 8.9, SD = 1.86 years) were randomized to one of three treatment arms over a 2-month period.
Methods: The CCRT arm received 24 one-hour sessions over 2 months, using Captain’s Log (BrainTrain
Corporation) programmed for games targeting working memory, attention, and visual–spatial analysis. These
games progressed in difficulty as the child’s performance improved. The second arm was a ‘‘limited CCRT’’
with the same games rotated randomly from simple to moderate levels of training. The third arm was a passive
control group receiving no training. All children were assessed at enrollment, 2 months (immediately following
CCRT), and 3 months after CCRT completion.
Results: The CCRT group had significantly greater gains through 3 months of follow-up compared to passive
controls on overall Kaufman Assessment Battery for Children–second edition (KABC-II) mental processing index
( p< .01), planning ( p= .04), and knowledge ( p= .03). The limited CCRT group performed better than controls on
learning ( p= .05). Both CCRT arms had significant improvements on CogState Groton maze learning ( p< .01);
although not on CogState attention/memory, TOVA/impulsivity, or behavior rating inventory for executive
function and child behavior checklist (psychiatric behavior/symptom problems) ratings by caregiver.
Conclusions: CCRT intervention can be effective for neurocognitive rehabilitation in children with HIV in low-
resource settings, especially in children who are clinically stable on ARV treatment.
Introduction
While initial focus in pediatric HIV was rightly placedon improved survival,1,2 there is increasing need to
focus on the quality of life for African children living with
HIV. Cognitive, psychiatric, and behavioral (neuropsycho-
logical) disorders are emerging as a major concern in highly
active antiretroviral therapy (HAART)-treated perinatally
infected children as they progress into adolescence.3,4 HIV
disease in children can significantly impair attention, mem-
ory, and visual–spatial processing speed,5–9 impairing school
performance. These are the very domains of neurocognitive
development in African children that have been most effec-
tively improved through computerized cognitive rehabilita-
tion treatment, computerized cognitive rehabilitation training
(CCRT).10
Preliminary studies of the neurocognitive benefits of CCRT
with Captain’s Log in Ugandan Children with HIV docu-
mented generalization improvements on standardized tests of
simple attention and maze learning.11 Similar improvements
were noted for Captain’s Log CCRT with children surviving
severe malaria.12,13 Although CCRT had an immediate effect
on cognitive outcomes pertaining to attention and some as-
pects of learning, the evidence was inconclusive in terms of
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neuropsychological or psychosocial behavioral benefit at
school or in the home.
In addition, although a hallmark feature of CCRT proce-
dures is to titrate difficulty of training with ongoing perfor-
mance, it was unclear how this individualized titration would
compare to computer games without this component. A re-
cent report comparing working memory (WM) CCRT with
and without performance titration concluded that titration is
important for neuroconnectivity to take place in underlying
brain regions leading to improved neurocognitive perfor-
mance.14 This study also compares CCRT with and without
titration in the context of a clinical trial and includes a third
group that does not receive CCRT. This took place with rural
children in Uganda in an impoverished region where the HIV/
AIDS epidemic has been most devastating and children face a
myriad of accompanying risk factors to their neuropsycho-
logical development.15,16
Methods
Participants
One hundred fifty-nine rural Ugandan children with WHO
Stage I or II HIV disease (6 to 12 years; 77 boys, 82 girls;
M = 8.9, SD = 1.86 years) were randomly assigned using a
random numbers table by the study manager to one of three
treatment arms over a 2-month period. The CCRT arm re-
ceived 24 one-hour sessions (3 days per week) using Cap-
tain’s Log (BrainTrain Corporation) programmed for games
targeting WM, attention, and visual–spatial analysis. This is
the recommended amount of training to achieve a significant
neurocognitive benefit.17–19 The second arm was a ‘‘limited
CCRT’’ with the same nine games rotated randomly through
the simplest to moderate levels of training (no titration). The
third arm was a passive control group receiving no computer
training. All children were assessed at enrollment, 2 months
(post-CCRT), and 3 months after CCRT (Fig. 1), at a private
study clinic in Kayunga.
Assessments were conducted in the local language of the
children (Luganda) by native speakers. Assessors were un-
aware of the child’s treatment arm. Socioeconomic status
(SES) and quality of home environment [home observation
for the measurement of the environment (HOME)] was as-
sessed upon enrollment. Children had access to daily medical
care and ART was initiated as per Uganda country 2008
guidelines.20 Informed written consent was obtained from the
child’s parent and signed assent from children age >7 years.
Consent and assent forms were read to the parent and child in
the local language. IRB approval for this study was obtained
from Makerere University School of Medicine, University of
Michigan, and Michigan State University. Research per-
mission was obtained from the Uganda National Council for
Science and Technology. Enrollment, assessment, and
training took place from 2011 to 2013.
Computerized cognitive rehabilitation training
Captain’s Log CCRT intervention. Captain’s Log mar-
keted by BrainTrain Corporation, is a comprehensive set of
computerized cognitive training games to improve a wide
range of cognitive skills.21 Research assistants supervising
CCRT spoke the local language of Luganda when instructing
the children on the training tasks. Training was done in the
child’s home after school so as to avoid bringing unnecessary
attention to the child and possible stigmatization by classmates.
We used the same configuration of Captain’s Log that was used
in our preliminary studies.10,11 A Uganda psychology team led
by M.J.B. and B.G. reviewed each of the possible training tasks
and selected nine games considered to be most culturally fair,
with three tasks emphasizing visual–spatial WM, vigilance
attention, and nonverbal reasoning, respectively.
All children were started at the simplest program level for
each task with training becoming more difficult as children
progressed. Sessions lasted 45 to 60 min. Captain’s Log has
an internal evaluator (CLIE) feature, which can be used to
audit the child’s rate and level of progress in each session,
while advancing to progressively more difficult items. We
used this feature to assess fidelity of CCRT.
Limited Captain’s Log CCRT. For the limited CCRT
group, we programmed Captain’s Log so that it rotated ran-
domly from simple to moderate levels of training for the entire
session. In every other respect, this training arm was like the
full CCRT arm.
Assessments for neuropsychological outcomes
Kaufman Assessment Battery for Children–second
edition. The Kaufman Assessment Battery for Children–
second edition (KABC-II) measures cognitive abilities in
children aged 3 to 18 years and is designed to minimize the
influence of language and cultural knowledge on test results.22
A special Nonverbal Index, used in this study, allows children
to be tested using only gestures to communicate instructions
and requires no understanding of English or the need to engage
in spoken verbal response. The KABC-II maintained its fac-
tor structure with Ugandan cerebral malaria survivors23 and is
sensitive to clinical biomarkers of disease status in Ugandan
children with HIV.9,24 The primary outcome variables were
the global scores of Sequential Processing (memory), Simul-
taneous Processing (visual–spatial analysis), Learning (imme-
diate and delayed memory), Planning (executive reasoning),
and Knowledge (crystallized intelligence). These (except
for Knowledge) are combined into a total mental processing
index (MPI).
CogState. This computerized neurocognitive assessment
was used in our prior CCRT studies.13,25–27 A 30-min session
is presented, which includes playing cards in a game-like
manner to assess memory, attention, discrimination learning,
and executive function that is nonlanguage dependent. It does
so with card detection (simple reaction time), identification
(choice reaction time), one-back WM, and one-card learning.
It also includes the Groton Maze Task that includes compo-
nents to measure visual-motor tracking (Maze Chase) and
executive functioning/planning (Maze Learning).
Test of variables of attention. The test of variables of
attention (TOVA) is a computer-based measure of sustained
attention and impulsivity.28 This test takes about 23 min to
administer and is designed to minimize cultural differences,
and has been used in Uganda to assess cognitive factors as-
sociated with pediatric HIV.9,24 The TOVA rapidly presents
simple geometric stimuli (i.e., a large open square with either
a solid smaller square at the top or bottom of the open square
for each presentation) to which the child must respond by
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pressing a hand switch. Performance outcomes include percent
trials with omissions errors of inattention (missing the correct
target), percent trials with commissions errors of impulsivity
(identifying the incorrect target as correct), mean response
time (speed of processing), and variability in response times
(consistency of attention processing). Summary performance
measures include an ADHD index score [ranging from -10
(High ADHD) to positive 10 (Highly attentive)] and a D prime
signal detection measure (sensitivity measures based on cor-
rect hits and correct misses).
Captain’s Log performance measures. The Captain’s
Log internal evaluator (CLIE) measures of session perfor-
mance were used to gauge fidelity of training during a
training session.21 These measure a child’s success at cor-
rectly responding to all training items for that session, ac-
curacy of responses, speed of processing, and processing
speed for correct responses to training items. These measures
were entered into the database for all 24 training sessions, and
improvements in the CLIE were correlated with improve-
ments in other neuropsychological and behavioral outcomes
for the CCRT and limited CCRT treatment arm children.
Bruininks/Oseretsky test for motor proficiency–second
edition. This is a comprehensive and sensitive instrument for
pediatric motor proficiency.29 Testing involves game-like
tasks that hold the child’s interest and are not verbally com-
plex. Composite scores include fine manual control, manual
FIG. 1. CONSORT diagram of flow of participants through clinical trial, including sample selection, randomization to
treatment arms, retention, and outcomes assessment number for final analyses. CCRT, computerized cognitive rehabilitation
training.
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Table 1. Demographic Characteristics and Outcomes at Baseline by Trial Arm
Characteristic
CCRT (N = 53),
n (%)
Limited CCRT
(N = 52), n (%)
Control
(N = 54), n (%)
p-Value for
comparison
by arm
Sex
Male 29 (55) 26 (49) 22 (42) .39
Female 24 (45) 27 (51) 31 (58)
County
Kayunga (periurban) 6 (11) 16 (30) 13 (25) .13
Kangulumira (rural) 11 (21) 7 (13) 12 (22)
Other (rural) 36 (68) 30 (57) 28 (53)
Caregiver
Mother 23 (43) 20 (38) 18 (34) .60
Other 30 (57) 33 (62) 35 (66)
On HAART at intake
No 27 (51) 15 (28) 25 (47) .04*
Yes 26 (49) 38 (72) 28 (53)
Mean (SD) Mean (SD) Mean (SD)
Age in years 9.20 (1.70) 8.86 (1.90) 8.65 (1.97) .30
Weight-for-age z scorea -1.27 (0.81) -1.14 (1.01) -1.17 (0.93) .74
Height-for-age z scorea -1.19 (1.42) -1.28 (1.44) -1.22 (1.34) .94
Socioeconomic score 9.68 (3.10) 11.00 (3.50) 10.04 (2.93) .09
HOME score total 28.19 (6.71) 29.87 (6.70) 29.34 (5.85) .40
CD4% 35.61 (14.06) 37.25 (15.47) 34.92 (15.22) .71
CD4_38H (CD4 activation) 5.12 (4.53) 5.23 (5.46) 6.09 (5.01) .56
CD8% 54.14 (13.23) 52.84 (14.27) 54.15 (13.44) .85
CD8_38H (CD8 activation) 17.00 (10.35) 14.84 (10.69) 18.21 (12.01) .29
Viral load (log) 7.21 (5.47) 5.72 (5.54) 7.66 (5.32) .17
KABC-IIb sequential processing 69.25 (9.95) 70.25 (8.70) 68.38 (10.22) .61
KABC-II simultaneous processing 59.85 (9.55) 60.81 (11.19) 61.96 (9.88) .83
KABC-II learning 64.01 (9.14) 71.00 (11.31) 64.81 (8.56) <.01**
KABC-II knowledge 63.62 (10.35) 64.85 (13.62) 62.13 (13.10) .53
KABC-II planning 59.23 (7.07) 58.61 (11.74) 59.90 (7.59) .81
KABC-II delayed recall 65.89 (8.50) 70.77 (10.78) 67.17 (7.95) .02*
KABC-II nonverbal index 57.68 (7.96) 58.23 (13.54) 58.36 (7.62) .94
KABC-II mental processing index 56.83 (7.16) 59.30 (8.50) 57.91 (6.54) .23
TOVA% omission errors 22.81 (20.39) 21.53 (21.13) 26.55 (20.81) .44
TOVA% commission errors 12.06 (10.77) 13.32 (13.46) 13.07 (11.12) .85
TOVA response time (msec) 651.81 (146.62) 653.42 (140.53) 692.77 (143.92) .25
TOVA response time variability (msec) 251.43 (72.02) 254.30 (82.27) 270.71 (67.41) .35
TOVA D prime signal detection score 2.42 (0.95) 2.28 (1.18) 2.06 (1.03) .52
TOVA ADHD index -6.09 (3.15) -5.35 (3.25) -5.99 (2.45) .38
BOT-2 total motor scorec 33.06 (4.40) 32.34 (5.24) 31.79 (5.40) .43
CogState, maze chase correct moves per second 0.20 (0.13) 0.22 (0.14) 0.19 (0.13) .46
CogState, moves maze learning correct moves
per second
0.10 (0.07) 0.09 (0.08) 0.07 (0.08) .07
CogState, detection time: playing card turning (log msec) 2.85 (0.11) 2.83 (0.12) 2.86 (0.10) .32
CogState, identification time: red playing card
turning log msec)
2.98 (0.10) 2.98 (0.10) 3.00 (0.09) .73
CogState, accuracy in one-card learning 0.62 (0.18) 0.60 (0.14) 0.57 (0.16) .26
CogState, accuracy in one-back card memory 0.67 (0.29) 0.70 (0.27) 0.58 (0.28) .10
BRIEF behavior regulation indexc 47.83 (11.13) 46.09 (9.09) 44.79 (7.12) .28
BRIEF metacognition index 50.04 (11.31) 47.00 (8.62) 49.13 (9.83) .32
BRIEF global executive composite 49.17 (11.13) 46.45 (8.12) 47.44 (8.27) .36
CBCL externalizing totalc 60.69 (9.92) 58.42 (6.88) 58.25 (7.52) .24
CBCL internalizing total 61.63 (8.73) 60.13 (8.63) 60.26 (10.23) .65
CBCL total 60.00 (9.53) 57.25 (7.52) 58.13 (8.25) .31
aWHO 2013 norms.
bStandardized scores using age-based norms.
cT scores using age- and gender-based norms.
*p < .05; **p < .01.
p-Values in bold are statistically significant.
BOT-2, Bruininks/Oseretsky test for motor proficiency–second edition; BRIEF, behavior rating inventory for executive function; CBCL,
child behavior checklist; CCRT, computerized cognitive rehabilitation training; HAART, highly active antiretroviral therapy; HOME,
home observation for the measurement of the environment; KABC-II, Kaufman Assessment Battery for Children–second edition; TOVA,
test of variables of attention.
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coordination, body coordination, strength and agility, and total
composite score. Its use in this study is particularly relevant
because of the pronounced motor impairment that seems to
accompany HIV-related neurocognitive delay compared with
impairment from severe malaria.30,31
Behavior rating inventory for executive function. The
behavior rating inventory for executive function (BRIEF) was
developed to especially evaluate behavioral and cognitive
problems as they relate to disruption of executive functions of
the brain resulting from mild brain injury and/or develop-
mental disorders. The BRIEF has been translated into the local
language of Luganda and structure validated for use with this
sample of children.33 It is also sensitive to the clinical status of
children in our sample.34 The BRIEF school-age form was
used for all children and takes*20–30 min to complete by the
parent or principal caregiver. The eight nonoverlapping clin-
ical scales form two broader indexes, Behavior Regulation
(three scales) and Metacognition (five scales), and a Global
Executive Composite score.
Achenbach child behavior checklist (parent). We chose
the child behavior checklist (CBCL) for our psychiatric as-
sessment measure because it is one of the most widely used
screening tools in child and adolescent psychiatry and pedi-
atrics and has been translated into the local language of
Table 2. Least Square Means from Longitudinal Model, Their Standard Errors by Trial Arm
Adjusted for Age, Being on HAART at Intake, Socioeconomic Score, Home Score, Recruitment
Location, KABC Learning and Delayed Recall Scores at Baseline, and Outcome Score at Baseline
Neuropsychology outcomes
CCRT LS
mean (SE)
Limited CCRT
LS mean (SE)
Control LS
mean (SE)
p-Value for
comparison
by arm
p-Value
for CCRT
vs. control
p-Value for
limited CCRT
vs. control
KABC-II sequential processinga 73.00 (0.97) 73.26 (0.99) 72.77 (0.91) .93 .86 .71
KABC-II simultaneous
processing
69.18 (1.15) 67.35 (1.19) 66.20 (1.09) .14 .05 .47
KABC-II learning* 72.23 (1.02) 72.43 (1.05) 69.66 (0.96) .08 .06 .05
KABC-II knowledge* 70.32 (0.97) 67.39 (1.00) 67.72 (0.91) .05 .04 .80
KABC-II planning 62.73 (0.74) 62.50 (0.81) 60.45 (0.77) .07 .03 .07
KABC-II delayed recall 71.93 (0.94) 71.02 (0.97) 69.60 (0.89) .17 .06 .27
KABC-II nonverbal index 63.67 (0.98) 63.04 (1.01) 61.26 (0.92) .15 .06 .19
KABC-II mental processing
index**
63.32 (0.60) 62.65 (0.62) 61.13 (0.57) .02 <.01 .07
TOVA% omission errors 22.35 (2.05) 23.18 (2.12) 21.18 (1.94) .77 .67 .48
TOVA% commission errors 10.93 (1.24) 11.63 (1.28) 9.67 (1.17) .50 .44 .25
TOVA response time (msec) 651.19 (12.53) 659.61 (12.92) 654.32 (11.87) .89 .85 .76
TOVA response time variability
(msec)
249.06 (7.85) 249.33 (8.09) 246.62 (7.43) .96 .81 .80
TOVA D prime signal detection
score
2.33 (0.12) 2.33 (0.13) 2.49 (0.12) .55 .34 .36
TOVA ADHD index -5.57 (0.40) -6.09 (0.42) -5.65 (0.38) .61 .87 .43
BOT-2 total motor scoreb 34.63 (0.47) 35.05 (0.47) 34.35 (0.43) .53 .65 .27
CogState, maze chase** correct
moves per second
0.47 (0.02) 0.48 (0.02) 0.31 (0.02) <.01 <.01 <.01
CogState, maze learning**
correct moves per second
0.25 (0.01) 0.23 (0.01) 0.15 (0.01) <.01 <.01 <.01
CogState, detection time* card
turned (log msec)
2.83 (0.01) 2.84 (0.01) 2.86 (0.01) .13 .05 .21
CogState, identification red card
turned (log msec)
2.97 (0.01) 2.98 (0.01) 2.97 (0.01) .65 .81 .50
CogState, accuracy in one-card
learning
0.63 (0.02) 0.60 (0.02) 0.61 (0.02) .36 .31 .67
CogState, accuracy in one-back
card memory
0.74 (0.03) 0.70 (0.03) 0.74 (0.03) .46 .97 .29
BRIEF behavior regulation indexb 45.05 (1.03) 43.76 (1.07) 44.90 (0.97) .61 .91 .42
BRIEF metacognition index 46.42 (0.99) 45.69 (1.03) 45.44 (0.93) .73 .45 .85
BRIEF global executive
composite index
45.34 (0.97) 44.87 (1.02) 45.40 (0.90) .91 .97 .69
CBCL Externalizing Total 56.77 (0.89) 55.19 (0.92) 54.88 (0.84) .24 .11 .80
CBCL Internalizing Total 59.35 (0.92) 56.69 (0.95) 57.70 (0.87) .11 .18 .42
CBCL Total 55.61 (0.83) 53.46 (0.86) 54.45 (0.78) .18 .29 .38
aStandardardized scores (using age-based norms).
bT scores using age- and gender-based norms.
*p < .05 for CCRT versus limited CCRT.
**p < .01 for CCRT versus limited CCRT.
p-Values in bold are statistically significant.
SE, standard errors.
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Luganda and structure validated for use with this sample of
children.33 It has been previously used by our group in pe-
diatric HIV research in Uganda.35,36 Although the CBCL can
provide a wide array of DSM-V and Syndrome scale scores,
our principal outcomes were Internalizing, Externalizing, and
Total symptoms.
Control variables. Outcome analyses were all adjusted
for age, gender, physical growth, socioeconomic status, qual-
ity of home environment score, recruitment location, and
HAART status (yes/no), based on past research within the Sub-
Saharan African context indicating the importance of both
basic demographic factors, as well as home environment and
occupation/income.37 The middle childhood version of the
Caldwell HOME38,39 was used to assess the stimulation and
learning opportunities offered by the child’s home environ-
ment. Along with the HOME, we also used a socioeconomic
evaluation scale of physical quality of the home environment
(SES score) previously validated with Ugandan children as
sensitive to long-term neurocognitive outcomes.40
CD4+ T-cell counts, immune activation, and viral load
testing. CD4, CD8, viral load, and other immunology mea-
sures were available from a blood draw taken within a week
from the time of neuropsychological assessment. CD4 T-cell
and CD8 T-cell activation level testing was performed on
EDTA anticoagulated whole blood using a fresh lyse no-wash
flow cytometry procedure. Blood was incubated with mono-
clonal antibodies, including CD3, CD8, CD4, CD38, and HLA
DR, then processed and acquired on a multilaser benchtop flow
cytometer. For each run of patient samples, a separate sample
of stabilized blood product (CD-Chex; Streck Laboratories)
was processed. CD4 T-cell and CD8 T-cell activation levels
were defined as % CD38 and HLA-DR coexpression.41
Statistical analyses. Adjusted means of the outcome
variables were obtained from linear mixed-effects (LME)
models with two repeated measures: (1) immediately after
CCRT (2 months after intake into the trial) and (2) 3 months
following completion of CCRT. Baseline measures of the
outcome variables were used as covariates for added control
of any preintervention differences among trial arms. The
success of randomization was checked by comparing base-
line variables by trial arm using the analyses of variance or
chi-square tests, as appropriate. Variables that differed by
trial arm at baseline were included as covariates in later an-
alyses. The repeated measures analyses were also adjusted
for the control variables. The primary analysis focused on the
main (additive) effect of the trial arm. The average differ-
ences among trial arms over time were reflected by the ad-
justed (least square) means that were output from the LME
model for each outcome variable. Additional analyses as-
sessed the fidelity of the intervention by correlating Captain’s
Log internal success measures with postintervention out-
comes. Finally, to explore whether the effect of the inter-
vention differed according to HIV immunological measures
or HAART status, the interactions of the trial arm with these
measures were added (one at a time) to the LME models.
Results
Table 1 provides descriptive statistical information for
these children following enrollment and before CCRT. Sig-
nificantly fewer children were on HAART at the start of the
study for the Limited CCRT arm, and they also had signifi-
cantly higher KABC-II Learning and Delayed Recall scores
related to Learning. Therefore, subsequent comparisons on
neuropsychological outcomes between trial arms included
these measures at baseline as covariates. There were no sig-
nificant changes between posttraining and 3-month follow-up
performance on any of our neuropsychological or behavioral
outcome measures; so these were combined in comparing
differences among trial arms for all of the LME analyses
reported below.
At posttraining and 3-month follow-up (Table 2), the CCRT
group had significantly greater gains compared to passive
controls on overall KABC-II performance (MPI, p< .01;
Fig. 2), Planning ( p= .04), and Knowledge ( p= .03). The
limited CCRT group performed better than controls on
Learning ( p= .05). Although marginal ( p< .06), the CCRT
group did not reach significance in terms of improvement on
Learning. Both CCRT arms had significantly greater gains on
CogState Groton maze chasing, on learning ( p< .01; Fig. 2),
and on card detection ( p= .05). However, there were no
treatment arm differences on any of the other CogState
memory or attention measures, TOVA/impulsivity, or BRIEF
FIG. 2. Box plots comparing RCT treatment arms (Full
CCRT, Limited CCRT, No CCRT) on KABC-II mental
processing index (upper graph; standardized score) and
CogState maze learning task (lower graph; correct moves per
second). Box represents median (bisect), upper and lower
quartile, and range of values, as well as individual outliers.
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and CBCL behavior/symptom ratings. In Table 3, significant
interaction effects evidenced that children on HAART at study
enrollment showed more dramatic KABC-II (Learning;
p< .05) and CogState (one-back card learning, p< .05) per-
formance benefit from the CCRT treatment arms that were not
previously evident (Table 3).
From first to last training session, both the full and limited
CCRT arms had comparable significant improvements on all
of the CLIE measures of fidelity of training. Table 4 includes
the correlations between CLIE from the last training session
and the KABC, CogState, TOVA, Bruininks/Oseretsky test
for motor proficiency–second edition (BOT-2), BRIEF, and
CBCL principal outcomes immediately following CCRT (2
months). CLIE for the last training session was highly cor-
related with KABC-II and CogState outcomes that signifi-
cantly improved from full CCRT ( p< .001). Even the TOVA
outcomes, which did not significantly improve from CCRT,
were significantly correlated to CLIE for both the CCRT and
limited CCRT treatment arms (Table 4).
Table 5 contains a summary of longitudinal models with
the interaction of trial arm by HIV immunological mea-
sures. The coefficients (slopes for each HIV immunologic
measure) are compared for CCRT versus control. These are
presented in this Table along with their standard errors. The
immunological measures of disease status at baseline (viral
load, CD4 counts, CD4 activation, CD8 counts, CD8 acti-
vation) were consistently predictive of a steeper slope
(greater training benefit for CCRT vs. control arm) for
KABC-II Planning, CogState card detection speed (one-step
attention measure), and card identification speed (two-step
attention) (Table 5).
Discussion
The results from this study demonstrate that CCRT-based
programs can be adapted for resource poor and rural non-
Western settings, and children can be motivated to take part in
these extended training regimens. It is also important to note
that those intervention children deriving the greatest benefit
from CCRT were also those who were the most clinically
stable study children on HAART at enrollment. These children
tended to have higher CD4, lower CD4 and CD8 activation,
and be virally suppressed Our preliminary study also demon-
strated the expected improvements in cognitive testing fol-
lowing training, with generalization to neurocognitive
performance measures entirely different than the nature of the
specific skills needed for Captain’s Log CCRT performance.
Trainers consistently observed in their session that the children
seemed to like and be well-motivated to take part in these
game-based training exercises. This would suggest improved
motivation and learning adherence, which have been associ-
ated with increased benefit from computerized training.10 In
addition, although examiners were present during training and
observed that all children maintained training regimens, fur-
ther research with similar CCRT programs may demonstrate
that it can be easily distributed in the field for children to use on
their own at home or in the school setting.
Astle et al. recently published a randomized controlled trial
of CCRT emphasizing WM training (see www.cogmed.edu)
with normal school children in Cambridge, UK.14 They
compared a full CCRT treatment arm of children receiving
from 20 to 25 sessions of Cogmed WM (visual and verbal)
CCRT to children receiving a nontitrating version of Cogmed
Table 3. KABC and CogState Outcomes of Those on HAART at Intake: Least Square Means
from Longitudinal Model, Their Standard Errors by Trial Arm Adjusted for Age,
Socioeconomic Score, Home Score, Recruitment Location, KABC Learning
and Delayed Recall Scores at Baseline, and Outcome Score at Baseline
CCRT LS
mean (SE)
Limited CCRT
LS mean (SE)
Control LS
mean (SE)
p-Value for
comparison
by arm
p-Value for
CCRT vs.
control
p-Value for
limited CCRT
vs. control
KABC-II sequential processinga 71.56 (1.35) 73.46 (1.18) 71.88 (1.29) .50 .87 .35
KABC-II simultaneous processing 68.74 (1.59) 65.40 (1.38) 64.75 (1.51) .14 .06 .74
KABC-II learning 71.09 (1.41) 72.04 (1.23) 68.19 (1.35) .08 .12 .03
KABC-II knowledge** 72.10 (1.44) 67.66 (1.23) 66.11 (1.37) <.01 <.01 .39
KABC-II planning* 62.67 (1.05) 61.88 (1.07) 58.93 (1.18) .04 .02 .07
KABC-II delayed recall 70.92 (1.23) 70.79 (1.08) 68.39 (1.18) .20 .12 .12
KABC-II nonverbal index 62.26 (1.42) 63.07 (1.25) 58.96 (1.35) .06 .08 .02
KABC-II mental processing index* 62.61 (0.87) 62.50 (0.76) 59.84 (0.83) .02 .02 .02
CogState, maze chase correct moves
per second**
0.41 (0.03) 0.42 (0.03) 0.26 (0.03) <.01 <.01 <.01
CogState, maze learning correct
moves per second**
0.20 (0.02) 0.21 (0.02) 0.13 (0.02) <.01 <.01 <.01
CogState, detection time card turned
(log mean msec)
2.87 (0.02) 2.86 (0.02) 2.86 (0.02) .72 .44 .86
CogState, identification time card
red suit (log mean msec)
3.00 (0.01) 3.00 (0.01) 2.99 (0.01) .62 .52 .34
CogState, accuracy in one-card
learning*
0.64 (0.02) 0.60 (0.02) 0.57 (0.02) .03 <.01 .24
CogState, accuracy in one-back card memory 0.68 (0.04) 0.63 (0.04) 0.67 (0.04) .65 .90 .47
aStandardardized scores (using age-based norms).
*p < .05 for CCRT versus limited CCRT.
**p < .01 for CCRT versus limited CCRT.
p-Values in bold are statistically significant.
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Table 4. Associations Between Captain’s Log Performance Success Composite Measure from the Last
Training Session with KABC and CogState, TOVA, BOT-2, BRIEF, and CBCL Outcomes at 2 months
Neuropsychology outcomes
Correlation, p-value,
N both CCRT
arms combined
Correlation,
p-value,
N CCRT
Correlation, p-value,
N Limited CCRT
KABC-II sequential processing 0.16890 0.28905 0.24716
.0865 .0377 .0773
104 52 52
KABC-II simultaneous processing 0.21027 0.40636 0.31516
.0322 .0028 .0229
104 52 52
KABC-II learning 0.37490 0.46468 0.25711
<.0001 .0005 .0658
104 52 52
KABC-II knowledge 0.14579 0.19680 0.22009
.1398 .1620 .1169
104 52 52
KABC-II planning 0.23646 0.19609 0.19574
.0248 .1865 .2084
90 47 43
KABC-II delayed recall 0.26410 0.29487 0.18437
.0067 .0338 .1907
104 52 52
KABC-II nonverbal index 0.23857 0.47394 0.18239
.0147 .0004 .1956
104 52 52
KABC-II mental processing index 0.29574 0.43314 0.23794
.0023 .0013 .0894
104 52 52
TOVA% omission errors -0.28890 -0.56424 -0.44374
.0029 <.0001 .0010
104 52 52
TOVA% commission errors -0.35133 -0.42219 -0.47518
.0003 .0018 .0004
104 52 52
TOVA response time -0.31594 -0.53459 -0.48492
.0011 <.0001 .0003
104 52 52
TOVA response time variability -0.47159 -0.66011 -0.62921
<.0001 <.0001 <.0001
104 52 52
TOVA D prime signal detection score 0.45219 0.65211 0.60422
<.0001 <.0001 <.0001
104 52 52
TOVA ADHD index 0.25659 0.36138 0.23341
.0086 .0085 .0959
104 52 52
BOT-2 total motor score 0.14691 0.27669 0.27980
.1367 .0471 .0445
104 52 52
CogState, maze chase correct moves per second 0.32833 0.40787 0.46928
.0007 .0027 .0004
104 52 52
CogState, maze learning correct moves per second 0.30791 0.48046 0.50062
.0015 .0003 .0002
104 52 52
CogState, detection time: playing card turned -0.20304 -0.38218 -0.38038
.0387 .0052 .0054
104 52 52
CogState, identification time: red playing card turned -0.19251 -0.48910 -0.33404
.0503 .0002 .0155
104 52 52
CogState, accuracy in one-card learning 0.20128 0.29283 0.47647
.0405 .0351 .0004
(continued)
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training. They used magnetoencephalography (MEG) to eval-
uate changes in resting-state connectivity between brain
regions underpinning WM performance based on their foun-
dational exploratory work with MEG.43 Changes in the brain
connectivity regions they examined from before to after train-
ing were significantly more pronounced in the full CCRT
arm compared to the limited CCRT arm, although some
changes were apparent there as well. Furthermore, the degree
of resting-state changes in the connectivity among these brain
regions was systematically related to the degree of improve-
ment in WM performance resulting from training in individual
children. These findings led Astle and colleagues to conclude
that theirs was the first systematic demonstration that CCRT in
children enhances neurophysiological brain connectivity intra-
and interhemispherically between brain regions known to be
related to verbal and visual–spatial WM, respectively (fron-
toparietal networks and both lateral occipital complex and
inferior temporal cortex).14,43
Because this effect is observed ‘‘at rest,’’ and children are
not performing any task during the scan, neither could these
training-related differences in brain region connectivity be
attributed to differences in motivation or strategy nor could
their documented brain effects be attributed to differences in
blood flow or metabolism, since MEG relies on the elec-
tromagnetic field activity of the brain at the microregional
level. Furthermore, improvements in WM after training were
associated with increased strength of neural connectivity at
rest, with the magnitude of these specific neurophysiological
changes being mirrored by individual gains in untrained WM
performance. These brain/behavior CCRT findings of Astle
and colleagues are important in substantiating the poten-
tial neurophysiological basis of positive brain plasticity in
children, hypothesized to be foundational to this perfor-
mance gains in the application of CCRT with Ugandan
children with HIV.
Through this and a set of other studies our group has
completed using CCRT in rural settings with HIV and se-
vere malaria survivors, we have demonstrated that the in-
tervention is feasible and effective.10,12,13,44 This study,
however, is the first to do so within a more rigorous RCT
study utilizing full and limited CCRT and passive control
arms. The Astle et al. study lacked a passive control arm for
performance and connectivity reference. It also lacked a
further posttraining follow-up to evaluate whether WM
gains and the enhanced neuroconnectivity from CCRT en-
dured months following the completion of training.14 Our
findings suggest that they might.
The next step will be to evaluate ways of bringing such
CCRT interventions to scale at a school- or community-wide
level. For example, in a pilot intervention with passive con-
trols from this study, we evaluated the neuropsychological
benefits of a cognitive games package developed for the
African context at Michigan State University, called brain
powered games (BPG).45 Twenty-four training sessions of
BPG over 2 months significantly improved TOVA and
CogState performance in these children,45 with anecdotal
evidence of how much children appreciated the BPG based
on their emphasis on African motif stimuli and music. A next
step might be to encourage in-country and local capacity for
stakeholders to incubate and evaluate such game packages
for scale-up and community-based intervention programs
and initiatives. Such programs would take advantage of in-
creased use of smartphones and tablets within the community
among children and adolescents.
Table 4. (Continued)
Neuropsychology outcomes
Correlation, p-value,
N both CCRT
arms combined
Correlation,
p-value,
N CCRT
Correlation, p-value,
N Limited CCRT
104 52 52
CogState, accuracy in one-back card memory 0.39737 0.61549 0.58064
<.0001 <.0001 <.0001
104 52 52
BRIEF behavior regulation index -0.21421 -0.12993 -0.19023
.0392 .3841 .2054
93 47 46
BRIEF metacognition index -0.33242 -0.39218 -0.32614
.0011 .0064 .0270
93 47 46
BRIEF global executive composite index -0.28405 -0.29307 -0.31017
.0058 .0456 .0359
93 47 46
CBCL externalizing total -0.19587 -0.16002 -0.15208
.0463 .2571 .2818
104 52 52
CBCL internalizing total -0.14429 0.02626 -0.02828
.1439 .8534 .8423
104 52 52
CBCL total -0.25922 -0.12003 -0.22522
.0079 .3967 .1084
104 52 52
Moderate correlations of 0.40 or higher in absolute value are bolded.
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Conclusions
CCRT interventions can be an effective and viable means
of neurocognitive rehabilitation in children with HIV in low-
resource settings. The titration feature of CRRT is important
for training benefit. Clinically stable children with HIV
seemed to derive great neuropsychological benefit from
CCRT. This suggests that the combination of HAART and
cognitive rehabilitation is important for these children. Fu-
ture studies are planned evaluating cognitive games for tab-
lets and smartphones that can make cognitive evaluation and
CCRT accessible on a mobile network.
Clinical Trial Registry
ClinicalTrials.gov Identifier: NCT00926003, Submitted
June 22, 2009.
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